Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation
In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research
Scope Of Panel’s Inquiry Outlined In Letter To Members
Institutions Required To Review For Bias under PHS Proposal
NIH Begins Process Of Extramural Program “Reinvention”
RFAs available: Chemoprevention Clinical Trials
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation